tiprankstipranks
Trending News
More News >
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market

Inovio Pharmaceuticals (INO) Income Statement

Compare
5,953 Followers

Inovio Pharmaceuticals Income Statement

Last quarter (Q3 2025), Inovio Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Inovio Pharmaceuticals's net income was $-45.50M. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 217.76K$ 832.01K$ 10.26M$ 1.77M$ 7.41M
Gross Profit
$ 217.76K$ 832.01K$ 10.26M$ 1.77M$ 7.41M
Operating Expenses
$ 112.62M$ 144.77M$ 277.84M$ 302.99M$ 131.49M
Depreciation and Amortization
$ 3.13M$ 3.50M$ 5.50M$ 4.73M$ 4.63M
EBITDA
$ -103.95M$ -130.39M$ -270.90M$ -296.56M$ -149.56M
Operating Income
$ -112.40M$ -143.94M$ -267.57M$ -301.22M$ -124.08M
Other Income/Expenses
$ 5.14M$ 8.82M$ -12.24M$ -2.44M$ -43.39M
Pretax Income
$ -107.25M$ -135.12M$ -279.82M$ -303.66M$ -167.47M
Net Income
$ -107.25M$ -135.12M$ -279.82M$ -303.66M$ -166.41M
Per Share Metrics
Basic EPS
$ -3.95$ -6.09$ -14.07$ -1.42$ -1.07
Diluted EPS
$ -3.95$ -6.09$ -14.07$ -1.42$ -1.07
Weighted Average Shares Outstanding
27.16M 22.17M 19.89M 214.62M 165.36M
Weighted Average Shares Outstanding (Diluted)
27.16M 22.17M 19.89M 214.62M 169.87M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History